We have conducted a variety of trials in analgesia that act centrally on the nervous system
We have performed First in Man studies for drugs intended to treat rheumatoid arthritis including dose escalation and bioavailability studies. In addition to these, various anti-inflammatory preparations have been tested for bioavailability, drug interactions, safety and tolerability.
We have facilitated trials which have looked into tamper proof formulations, anti-abuse preparations and food/diet interactions.
We are in close proximity to three of the tertiary care hospitals in Northern Ireland and Supplementary Accreditation makes us a very practical and safe place for conducting trials for drugs involving actions on the CNS.
Our volunteer database comprises 10,000 Healthy Volunteer subjects and a sizeable RA database, which is readily boosted when the need arises through BioKinetic advertising campaigns.
We have access to Consultant Specialists in Anaesthesia and Pain Management and work closely with Rheumatology specialist Dr. Gary Meenagh in the recruitment of arthritic volunteers. For more details, visit: rheumdoc.com
We have utilized a wide range of drug delivery routes that include capsule, transdermal, sublingual, intravenous (bolus doses and infusions), intramuscular and subcutaneous.
Our in-house pharmacist is expert in devising novel blinding methods and is Project Manager on opioid analgesic trials, to allow immediate communication between sponsor and unit regarding progress in studies; particularly relevant in those involving rapid dose escalation.
BioKinetic has successfully completed all studies to the required standard and timelines as set out at study initiation. Repeat clients account for over 80% of our business.
We have conducted over 40 studies in pain management and arthritis to date.